W F Owen

3.1k total citations · 2 hit papers
22 papers, 2.6k citations indexed

About

W F Owen is a scholar working on Physiology, Rheumatology and Immunology. According to data from OpenAlex, W F Owen has authored 22 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 8 papers in Rheumatology and 8 papers in Immunology. Recurrent topics in W F Owen's work include Eosinophilic Disorders and Syndromes (7 papers), Asthma and respiratory diseases (7 papers) and Immune Cell Function and Interaction (6 papers). W F Owen is often cited by papers focused on Eosinophilic Disorders and Syndromes (7 papers), Asthma and respiratory diseases (7 papers) and Immune Cell Function and Interaction (6 papers). W F Owen collaborates with scholars based in United States, Netherlands and Germany. W F Owen's co-authors include K. Frank Austen, David S. Silberstein, R L Stevens, M.E. Rothenberg, Marc E. Rothenberg, Roy J. Soberman, Judith C. Gasson, Richard L Stevens, Jennifer Woods and Albert L. Sheffer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

W F Owen

22 papers receiving 2.4k citations

Hit Papers

Human eosinophils have prolonged survival, enhanced funct... 1987 2026 2000 2013 1988 1987 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W F Owen United States 19 1.2k 1.0k 744 447 408 22 2.6k
Andrea Matucci Italy 32 1.1k 0.9× 1.3k 1.2× 675 0.9× 609 1.4× 303 0.7× 114 3.2k
Cheryl Protheroe United States 25 1.1k 0.9× 1.2k 1.2× 794 1.1× 291 0.7× 1.1k 2.6× 33 2.6k
Alessandra Vultaggio Italy 32 810 0.6× 1.1k 1.1× 512 0.7× 628 1.4× 192 0.5× 124 2.9k
Seiji Mita Japan 23 593 0.5× 1.2k 1.2× 387 0.5× 236 0.5× 358 0.9× 60 2.5k
Motoyasu Iikura Japan 25 1.2k 1.0× 2.1k 2.0× 304 0.4× 610 1.4× 763 1.9× 84 3.0k
David Gossage United States 17 1.7k 1.4× 567 0.5× 284 0.4× 456 1.0× 605 1.5× 29 2.4k
Holly Evanoff United States 27 412 0.3× 1.2k 1.2× 407 0.5× 406 0.9× 266 0.7× 33 3.0k
Claire Emson United States 25 1.1k 0.9× 1.2k 1.2× 128 0.2× 544 1.2× 354 0.9× 44 3.1k
Tomomitsu Hirota Japan 30 1.1k 0.9× 903 0.9× 138 0.2× 599 1.3× 306 0.8× 74 2.4k
Aarnoud Huissoon United Kingdom 27 412 0.3× 1.0k 1.0× 380 0.5× 772 1.7× 146 0.4× 68 2.7k

Countries citing papers authored by W F Owen

Since Specialization
Citations

This map shows the geographic impact of W F Owen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W F Owen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W F Owen more than expected).

Fields of papers citing papers by W F Owen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W F Owen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W F Owen. The network helps show where W F Owen may publish in the future.

Co-authorship network of co-authors of W F Owen

This figure shows the co-authorship network connecting the top 25 collaborators of W F Owen. A scholar is included among the top collaborators of W F Owen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W F Owen. W F Owen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ameer, Guillermo A., Hidde L. Ploegh, David T. Ting, et al.. (2001). A novel immunoadsorption device for removing β2-microglobulin from whole blood. Kidney International. 59(4). 1544–1550. 24 indexed citations
2.
Lowrie, Edmund G., Glenn M. Chertow, Nancy L. Lew, J. Michael Lazarus, & W F Owen. (1999). The urea {clearance × dialysis time} product (Kt) as an outcome-based measure of hemodialysis dose. Kidney International. 56(2). 729–737. 114 indexed citations
3.
Hou, Fan Fan, Glenn M. Chertow, Jonathan Kay, et al.. (1997). Interaction between β2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis. Kidney International. 51(5). 1514–1519. 48 indexed citations
4.
Boyce, Joshua A., DS Friend, Michael F. Gurish, K. Frank Austen, & W F Owen. (1996). Constitutive production of granulocyte/macrophage colony-stimulating factor by hypodense mononuclear eosinophils developed in vitro from hybrid eosinophil/basophil granulocytes.. Proceedings of the National Academy of Sciences. 93(6). 2436–2441. 8 indexed citations
5.
Boyce, Joshua A., DS Friend, Ryoji Matsumoto, K. Frank Austen, & W F Owen. (1995). Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate.. The Journal of Experimental Medicine. 182(1). 49–57. 75 indexed citations
6.
Stricker, Raphael B., Katherine Sanders, W F Owen, D Kiprov, & Robert G. Miller. (1992). Mononeuritis multiplex associated with cryoglobulinemia in HIV infection. Neurology. 42(11). 2103–2103. 13 indexed citations
7.
Drew, William, Richard C. Miner, David F. Busch, et al.. (1991). Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection. The Journal of Infectious Diseases. 163(4). 716–719. 295 indexed citations
10.
Owen, W F, et al.. (1990). Human fibroblasts maintain the viability and augment the functional response of human neutrophils in culture.. Journal of Clinical Investigation. 85(2). 601–604. 19 indexed citations
11.
Owen, W F, Rebecca D. Folkerth, Robert J. Anderson, et al.. (1990). Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.. Proceedings of the National Academy of Sciences. 87(21). 8647–8651. 77 indexed citations
12.
Owen, W F, Marc E. Rothenberg, Peter F. Weller, et al.. (1989). Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome.. The Journal of Experimental Medicine. 170(1). 343–348. 193 indexed citations
13.
Rothenberg, M.E., R L Stevens, David S. Silberstein, et al.. (1989). IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity.. The Journal of Immunology. 143(7). 2311–2316. 243 indexed citations
14.
Lam, B, W F Owen, K. Frank Austen, & Roy J. Soberman. (1989). The Identification of a Distinct Export Step following the Biosynthesis of Leukotriene C4 by Human Eosinophils. Journal of Biological Chemistry. 264(22). 12885–12889. 104 indexed citations
15.
Rothenberg, M.E., W F Owen, David S. Silberstein, et al.. (1988). Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.. Journal of Clinical Investigation. 81(6). 1986–1992. 395 indexed citations breakdown →
16.
Rothenberg, Marc E., W F Owen, David S. Silberstein, et al.. (1988). 165 Cytokine regulation of human eosinophil viability, density, and function. Journal of Allergy and Clinical Immunology. 81(1). 209–209. 5 indexed citations
17.
Rothenberg, Marc E., Joel L. Pomerantz, W F Owen, et al.. (1988). Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor.. Journal of Biological Chemistry. 263(27). 13901–13908. 78 indexed citations
18.
Owen, W F, Marc E. Rothenberg, David S. Silberstein, et al.. (1987). Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.. The Journal of Experimental Medicine. 166(1). 129–141. 336 indexed citations breakdown →
19.
Owen, W F, Roy J. Soberman, Takayuki Yoshimoto, et al.. (1987). Synthesis and release of leukotriene C4 by human eosinophils.. The Journal of Immunology. 138(2). 532–538. 99 indexed citations
20.
Silberstein, David S., W F Owen, Judith C. Gasson, et al.. (1986). Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.. The Journal of Immunology. 137(10). 3290–3294. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026